HRT FINANCIAL LP

Position in RGNX — REGENXBIO Inc.

CIK 1475597 NEW YORK, NY

Position in RGNX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$2,945,477

-$1,373,299 QoQ

Shares Held

351,489

+17.2% QoQ

Ownership

0.680%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $416,760,191 across 198 Biotechnology names. RGNX ranks #35 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	128,633	$42,560,800
2	IBRX	ImmunityBio, Inc.	3,925,446	$30,108,170
3	EXEL	Exelixis, Inc.	460,585	$19,754,490
4	IONS	Ionis Pharmaceuticals Inc	252,250	$18,941,452
5	MRNA	Moderna, Inc.	368,421	$18,715,786
6	ARGX	Argenx SE	18,754	$13,695,108
7	RARE	Ultragenyx Pharmaceutical Inc.	613,229	$12,847,147
8	IOVA	Iovance Biotherapeutics, Inc.	3,486,299	$12,236,909

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,945,477	351,489	+17.2%	Shares	Defined	2026-05-14
2025-12-31	$4,318,776	299,915	+74.2%	Shares	Defined	2026-02-12
2025-09-30	$1,661,594	172,186	-6.1%	Shares	Defined	2025-11-14
2025-03-31	$1,311,481	183,424	-49.5%	Shares	Defined	2025-05-15
2024-12-31	$2,809,105	363,403	+55.3%	Shares	Defined	2025-02-14
2024-09-30	$2,454,649	233,999	+1378.4%	Shares	Defined	2024-11-12
2023-12-31	$284,112	15,828	-16.4%	Shares	Defined	2024-02-09
2023-06-30	$378,590	18,939	-57.4%	Shares	Defined	2023-08-11
2022-12-31	$1,008,398	44,462	+473.6%	Shares	Defined	2023-02-10
2022-09-30	$204,858	7,751	+12.4%	Shares	Defined	2022-11-14
2020-12-31	$312,757	6,895	-78.7%	Shares	Defined	2021-02-16
2020-09-30	$891,895	32,409	—	Shares	Defined	2020-11-13
No filing history on record for this holder in this stock.